ISPE Announces 2007-2008 International Board of Directors
(TAMPA. FLORIDA, USA, 12 NOVEMBER 2007) – ISPE, a global not-for-profit association of 25,000 pharmaceutical manufacturing professionals, announced its newly elected International Board of Directors for the 2007-2008 term. The Society made the announcement last week during the ISPE 2007 Annual Meeting in Las Vegas, Nevada, USA, which attracted more than 2,700 pharmaceutical manufacturing professionals.
The Board of Directors is responsible for creating the Society’s vision, establishing its basic goals and policies, approving its financial direction and providing guidance to ISPE councils, committees, task teams, and professional staff. Each Member will serve the Society for a one-year term beginning 6 November 2007. ISPE new leaders are:
Chair
Bruce Davis – AstraZeneca, Global Capital Director, Cheshire, UK
Vice Chair
Charles P. Hoiberg, PhD - Pfizer, Executive Director, Regulatory CMC - Policy and Regulatory Environment group, Maryland, USA
Treasurer
Alan Mac Neice - Elan’s Biopharmaceutical Science, Project Director for Biologics, Athlone, Ireland
Secretary
Andre Walker - Biogen Idec’s Commercial and Clinical Operations, Director of Manufacturing Engineering, Massachusetts, USA
New Directors:
Nuala Calnan - Project Management Group, Principal Consultant, Dublin, Ireland
Charlotte Enghave, PhD - NNE Pharmaplan, Finished Product Department, Senior Consultant, Soeberg, Denmark
Nigel Frost - Thermal Transfer Ltd., Managing Director, Derbyshire, UK
Damian Greene - Pfizer Global Manufacturing (PGM), Director/Team Leader, New York, USA
David E. Petko, PE - Auxilium Pharmaceuticals, Inc., Senior Director, Pennsylvania, USA
Re-Elected Directors:
Arthur (Randy) Perez, PhD - Novartis Pharmaceuticals Corp., IT Quality Assurance, Executive Expert, New Jersey, USA
Stephanie Wilkins, PE - PharmaConsult US, Inc., President, New Jersey, USA
Directors elected in 2006 to serve a two-year term:
Jane R. Brown – GlaxoSmithKline, Manager, GMP Compliance, North Carolina, USA
Joan Gore - Eli Lilly and Co., Manager of the US Clinical Trial Planning and Packaging, Indiana, USA
Tomiyasu Hirachi - Qualicaps Co., Ltd., Representative Director and President, Tokyo, Japan
John Nichols - Foster Wheeler, Director of Pharmaceutical Technology, Berkshire, UK
About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical manufacturing professionals in 90 countries around the globe. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; and its Asia Pacific office in Singapore. Visit www.ISPE.org for additional Society news and information.